Skip to content

Natrelle 133S Tissue ExpandersRecalls & reported problems across all models

Allergan, Inc. · 25 models in the FDA device registry

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
319
Deaths reported
0
Injuries reported
281
Recalls
0

We found 25 models of Natrelle 133S Tissue Expanders by Allergan, Inc. in the FDA's device registry (GUDID). Together they are named in 319 adverse event reports in the FDA's MAUDE database, received between May 31, 2019 and Sep 30, 2026 — classified as 281 injuries, 38 malfunctions.

The most frequently reported specific device problem is “Fluid/Blood Leak” (176 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 2 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 1 reportsMar 2025: 4 reportsApr 2025: 2 reportsMay 2025: 6 reportsJun 2025: 11 reportsJul 2025: 1 reportsAug 2025: 5 reportsSep 2025: 6 reportsOct 2025: 1 reportsNov 2025: 2 reportsDec 2025: 3 reportsJan 2026: 3 reportsFeb 2026: 1 reportsMar 2026: 3 reportsApr 2026: 2 reportsMay 2026: 1 reportsJun 2026: 2 reportsJul 2026: 3 reportsAug 2026: 0 reportsSep 2026: 6 reportsOct 2026: 0 reports20242025202611
Last 36 months. The most recent month may be incomplete.

Most reported Natrelle 133S Tissue Expanders problems

Device problems

  • Fluid/Blood Leak176
  • Adverse Event Without Identified Device or Use Problem64
  • Break31
  • Deflation Problem13
  • Improper or Incorrect Procedure or Method8
  • Device Appears to Trigger Rejection6
  • Device Handling Problem6
  • Material Rupture6

Patient problems

  • Failure of Implant210
  • Unspecified Infection58
  • No Clinical Signs, Symptoms or Conditions19
  • Seroma17
  • Necrosis7
  • Wound Dehiscence7
  • Cellulitis5
  • No Patient Involvement5

Natrelle 133S Tissue Expanders models

25 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent Natrelle 133S Tissue Expanders adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Allergan, Inc. products

All Allergan, Inc. devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page